Neoadjuvant immunochemotherapy for resectable esophageal cancer: A study on efficacy and safety
The combination of immunosuppressants and chemotherapy has reshaped the treatment landscape for esophageal cancer (EC). This study aimed to evaluate the effectiveness and safety of a neoadjuvant immunochemotherapy (nICT) regimen in patients with resectable EC. A total of 99 eligible patients were i...
محفوظ في:
| المؤلفون الرئيسيون: | , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
2025-04-01
|
| سلاسل: | Biomolecules & Biomedicine |
| الموضوعات: | |
| الوصول للمادة أونلاين: | http://www.bjbms.org/ojs/index.php/bjbms/article/view/11806 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|